Companion Medical announced that it has received clearance from the Food and Drug Administration (FDA) for a new bolus calculator for fixed dosing and meal estimation to be used with the InPen system.

New Smart MDI system will be the first system to deliver real-time, personalized insights on when and how much to dose including for missed or inaccurate mealtime doses. GALWAY, Ireland, Nov. 20, 2024 ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted clearance for the Android version of the InPen app, making ...

Medtronic (MDT) announced FDA clearance for its new InPen app featuring missed meal dose detection, paving the way for the launch of its Smart MDI system with the Simplera continuous glucose monitor, ...

This story was originally published on MedTech Dive. To receive daily news and insights, subscribe to our free daily MedTech Dive newsletter. Medtronic received Food and Drug Administration clearance ...

A new reusable insulin injector pen combined with a smartphone app that helps insulin-dependent diabetes patients calculate their doses and keeps track of injection data is now available in the United ...

Medtronic MDT continues to grab headlines with respect to its Diabetes management business update. Following two back-to-back European approvals last month for its InPen smart insulin pen as well as ...

Medtronic's launch of a new version of its smart insulin pen with integrated continuous glucose monitoring (CGM) is the first such "connected" device for use by people with diabetes who use multiple ...

SAN DIEGO, July 19, 2018 /PRNewswire/ -- Companion Medical, a leader in the development of advanced technology to improve diabetes care, has received CE mark for the InPen system, paving the way for ...